Sg3 Management, LLC Abbott Laboratories Call Options Transaction History

Sg3 Management, LLC

11 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 15, 2022	SELL	$102.07 - $123.37 $3.06 Million - $3.7 Million	-30,000 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$114.02 - $139.04 $456,080 - $556,160	4,000 Added 15.38%	30,000 $3.55 Million
Q3 2020 Nov 13, 2020	SELL	$91.64 - $111.29 $21.3 Million - $25.9 Million	-232,500 Reduced 89.94%	26,000 $2.83 Million
Q2 2020 Aug 14, 2020	BUY	$76.57 - $98.0 $19.8 Million - $25.3 Million	258,500 New	258,500 $23.6 Million
Q3 2019 Nov 13, 2019	SELL	$81.84 - $88.74 $1.48 Million - $1.61 Million	-18,100 Closed	0 $0
Q2 2019 Aug 09, 2019	SELL	$72.88 - $85.0 $2.73 Million - $3.18 Million	-37,400 Reduced 67.39%	18,100 $1.52 Million
Q1 2019 May 14, 2019	BUY	$66.22 - $80.06 $3.39 Million - $4.1 Million	51,200 Added 1190.7%	55,500 $4.44 Million
Q2 2017 Feb 26, 2018	BUY	N/A	4,257 Added 9900.0%	4,300 $209,000
Q2 2017 Jan 25, 2018	SELL	N/A	-12,357 Reduced 99.65%	43 $3,000
Q1 2017 Feb 26, 2018	BUY	N/A	12,276 Added 9900.0%	12,400 $551,000
Q1 2017 Jan 25, 2018	BUY	N/A	124	124 $0

3,189

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $197B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Sg3 Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg3 Management, LLC with notifications on news.